
NASDAQHealthcareMedical - Devices
Latest quote
$3.19
−$0.07 · -2.15%
Sensus Healthcare, Inc. operates as a medical technology enterprise, manufacturing and distributing radiation therapy apparatuses to medical institutions across the globe. The company's portfolio leverages superficial radiation therapy (SRT), a cutting-edge low-energy X-ray methodology. Their product line features the SRT-100, a photon X-ray system for low-energy superficial radiotherapy. This device presents a non-surgical alternative for patients dealing with non-melanoma skin cancers, including basal cell and squamous cell carcinomas, alongside other dermatological issues like keloids. Another key offering is the SRT-100 Vision, which incorporates a specialized SRT treatment planning application. This application seamlessly integrates an embedded high-frequency ultrasound imaging module, tools for volumetric tumor analysis, beam margin delineation, and dosimetry parameter configuration. In addition, Sensus Healthcare provides the SRT-100 Plus, the Sentinel service program to ensure system protection for its clients, and options for in-office laser rentals. They also supply various consumable items, such as replacement lead shielding, disposable radiation safety gear like aprons and eye shields, ultrasound probe film, and single-use applicator tips designed to treat lesions of different sizes and on various body areas. Founded in 2010, Sensus Healthcare, Inc. maintains its corporate headquarters in Boca Raton, Florida.
Previous close
$3.19
−$0.07 · -2.15%
Regular session · ET · Market data may be delayed.
Sensus Healthcare, Inc. operates as a medical technology enterprise, manufacturing and distributing radiation therapy apparatuses to medical institutions across the globe. The company's portfolio leverages superficial radiation therapy (SRT), a cutting-edge low-energy X-ray methodology. Their product line features the SRT-100, a photon X-ray system for low-energy superficial radiotherapy. This device presents a non-surgical alternative for patients dealing with non-melanoma skin cancers, including basal cell and squamous cell carcinomas, alongside other dermatological issues like keloids. Another key offering is the SRT-100 Vision, which incorporates a specialized SRT treatment planning application. This application seamlessly integrates an embedded high-frequency ultrasound imaging module, tools for volumetric tumor analysis, beam margin delineation, and dosimetry parameter configuration. In addition, Sensus Healthcare provides the SRT-100 Plus, the Sentinel service program to ensure system protection for its clients, and options for in-office laser rentals. They also supply various consumable items, such as replacement lead shielding, disposable radiation safety gear like aprons and eye shields, ultrasound probe film, and single-use applicator tips designed to treat lesions of different sizes and on various body areas. Founded in 2010, Sensus Healthcare, Inc. maintains its corporate headquarters in Boca Raton, Florida.
Day range
Current $3.19
52-week range
Current $3.19
Regular session · ET · Market data may be delayed.
AI-powered factor overview
GoAI Score
Hold
Wait — insufficient conviction to act
Valuation
57
Fair Value
Sentiment
72
Bullish
Risk
69
High Risk
Momentum
26
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Sensus Healthcare, Inc. operates as a medical technology enterprise, manufacturing and distributing radiation therapy apparatuses to medical institutions across the globe. The company's portfolio leverages superficial radiation therapy (SRT), a cutting-edge low-energy X-ray methodology. Their product line features the SRT-100, a photon X-ray system for low-energy superficial radiotherapy. This device presents a non-surgical alternative for patients dealing with non-melanoma skin cancers, including basal cell and squamous cell carcinomas, alongside other dermatological issues like keloids. Another key offering is the SRT-100 Vision, which incorporates a specialized SRT treatment planning application. This application seamlessly integrates an embedded high-frequency ultrasound imaging module, tools for volumetric tumor analysis, beam margin delineation, and dosimetry parameter configuration. In addition, Sensus Healthcare provides the SRT-100 Plus, the Sentinel service program to ensure system protection for its clients, and options for in-office laser rentals. They also supply various consumable items, such as replacement lead shielding, disposable radiation safety gear like aprons and eye shields, ultrasound probe film, and single-use applicator tips designed to treat lesions of different sizes and on various body areas. Founded in 2010, Sensus Healthcare, Inc. maintains its corporate headquarters in Boca Raton, Florida.
Day range
Current $3.19
52-week range
Current $3.19
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 27.48M USD | 41.81M USD | 24.41M USD | 44.53M USD | 27.04M USD |
| Cost of goods sold | 15.62M USD | 17.38M USD | 10.35M USD | 14.9M USD | 10.05M USD |
| Gross profit | 11.87M USD | 24.43M USD | 14.06M USD | 29.63M USD | 16.99M USD |
| Research and development | 7.78M USD | 4.22M USD | 3.68M USD | 3.46M USD | 3.44M USD |
| Selling, general, and administrative | 14.4M USD | 12.13M USD | 10.76M USD | 11.34M USD | 9.43M USD |
| Operating expenses | 22.17M USD | 16.34M USD | 14.44M USD | 14.8M USD | 12.87M USD |
| Interest income | 683K USD | 932K USD | 992K USD | 382K USD | 2K USD |
| Interest expense | — | — | — | 2K USD | 1K USD |
| Depreciation and amortization | 386K USD | 432K USD | 461K USD | 509K USD | 613K USD |
| Operating income | −10.31M USD | 8.09M USD | −382K USD | 14.83M USD | 4.12M USD |
| Net income | −7.72M USD | 6.65M USD | 485K USD | 24.24M USD | 4.12M USD |
Company facts updated Sep 6, 2026.
Third-party consensus; not a GoAI recommendation.
Average target
$4.75
48.90% upsideFunds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI1.44M0.00%2.3T USD0.03%$379.73-0.32%
Vanguard Extended Market ETFVXF450.09K0.00%93.7B USD0.05%$242.66+0.14%
iShares Micro-Cap ETFIWC153.37K0.01%1.47B USD0.60%$196.25+0.69%
Dimensional - US Small Cap ETFDFAS92.93K0.00%15.54B USD0.26%$82.20+0.18%
Dimensional - US Small Cap Value ETFDFSV91.13K0.00%8.42B USD0.30%$40.44+0.50%
Dimensional - US Core Equity 2 ETFDFAC68.84K0.00%49.14B USD0.17%$45.72-0.09%
Avantis U.S. Small Cap Equity ETFAVSC65.3K—3.11B USD0.25%$73.23+0.55%
U.S. Micro Cap Portfolio ETFDFMC44.02K0.00%7.81B USD0.43%$60.36+0.60%
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Extended Market ETFVXF
iShares Micro-Cap ETFIWC
Dimensional - US Small Cap ETFDFAS
Dimensional - US Small Cap Value ETFDFSV
Dimensional - US Core Equity 2 ETFDFAC
Avantis U.S. Small Cap Equity ETFAVSC
U.S. Micro Cap Portfolio ETFDFMCAI-generated and delayed market data for informational and educational purposes only. Not investment advice.